The Department for Paediatric Cardiology at the University Medical Centre, at Johannes Gutenberg University, in Mainz, has extended its range of services for lower impact treatment According to the birth register in Mainz, an annual 1.26% of newborns are diagnosed with congenital heart defects, making these the most common malformation.
In his lecture Focus on new therapy strategies for heart attacks, Prof. Hans Michael Piper, President of this year's Congress of the German Cardiac Society, gave some fascinating insights in to therapeutic measures after heart attacks.
Competitive or complementary? By Florian Schwarz BS, Balazs Ruzsics MD PhD and U. Joseph Schoepf MD, of the Radiology and Medicine Departments, at the Medical University of South Carolina, Charleston, USA.
Recent studies show that drug-eluting-stents perform superior than bare metal stents in the treatment of high-risk cardiac patients. At ComPaMED 2007, the Germany based company HEMOTEQ, leading designer and manufacturer of ultra-thin coatings for medical devices, presented their solutions for customized coating of stents.
Urinary tract infections caused by catheterisation are a common and nasty affliction for the disabled, elderly and hospital patients.
USA - A next-generation radiofrequency ablation catheter - the VNUS ClosureFASTTM - has been used by surgeon Phillip Levin MD, at Cedars-Sinai, in Los Angeles, California. An expert in VNUS closure procedure, Dr Levin has treated approximately 300 patients since 2003 with the ClosureFASTTM catheter's predecessor.
The new £2 million remote access stereotaxis catheter laboratory at London's Heart Hospital, funded by the British Heart Foundation (BHF), is the first of its kind in the UK and one of only 40 worldwide.
The Cardiocentro Ticino in Lugano, Switzerland ' a tertiary care centre specialising in treating patients with coronary artery disease ' carries out around 300 major operations and 2,000 invasive coronary angiographies annually. Six months ago, the hospital acquired state-of-the art equipment, including GE's LightSpeed VCT XT.
The Sensei Robotic Catheter System, a first generation robotic platform launched by Hansen Medical at the USA's Heart Rhythm Society Scientific Sessions in May this year, is in use in Europe.
Boston Scientific Corporation has commenced enrolment of a targeted 1,500 patients for the Taxus Perseus clinical trials, planned to take place in 100 international centres.
Ultrasound contrast agents (USCA) or echo enhancers consist of minute gas containing microbubbles that have a high reflectivity when exposed to an ultrasound field. The history of USCA started in the mid of the 1960s. The cardiologist Joyner performed echo cardiography during the injection of saline solution into the aortic root via a catheter. During the injection he observed bright signals on…
The debate between carotid artery stenting (CAS) and carotid endarterectomy (CEA) - the surgical approach - for treating a narrowing of the carotid artery in the neck to prevent stroke has tipped in favour of the more proven procedure of operation.
Unlike conventional radiation therapy, selective, internal radiotherapy (SIRT), uses tiny radio-active microspheres to attack malignant liver tumours.
Smiths Medical launched a newly range of advanced embryo replacement catheters for in vitro fertilisation.
Freezing abnormal electrical pathways in the hearts of young patients may be a safer alternative to zapping them with powerful radiofrequency probes to treat tachycardias and other arrhythmias, according to Dr Fabrizio Drago, of the Bambino Gesù Hospital, Rome. ‘If you have a child with a supraventricular tachycardia due to a re-entry circuit, or a target very close to the atrioventricular…
Berlin became the venue for the German Congress of Radiology this May, for the second time. 118 exhibitors showcased products on 4,900 square metres, and the event attracted 7,000 radiologists, and 970 medical-technological radiology assistants (MTRA) to convene simultaneously, leading some to suggest the city will be the future home of the Congress.
Italy - A remotely-controlled catheter device guided by magnetic fields provides a safe and practical method for delivering radio frequency ablation treatment in the hearts of patients with atrial fibrillation, according to a new study (Pub: Journal of the American College of Cardiology. 4/4/06).
Many companies are competing to develop the ideal transcatheter heart valve and catheter-based valve replacement procedures, which are revolutionizing valve replacement for larger patients.
Germany - Following positive results in numerous animal studies and the first human implantations of the Biontronik Absorbable Metal Stent (AMS) in below-the-knee arteries that confirmed device safety, at the end of July the first patients (worldwide) received AMS implants.
Ballon Brachytherapy and effective drug combination.
France - Four studies of three TAXUS paclitaxel-eluting stents have demonstrated their safety and efficacy, according to the maker, Boston Scientific Corporation of Natick, Maryland, USA.